Antimetabolites and cancer: emerging data with a focus on antifolates.
about
Navigating the human metabolome for biomarker identification and design of pharmaceutical molecules.A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer.Mn porphyrin regulation of aerobic glycolysis: implications on the activation of diabetogenic immune cells
P2860
Antimetabolites and cancer: emerging data with a focus on antifolates.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Antimetabolites and cancer: emerging data with a focus on antifolates.
@ast
Antimetabolites and cancer: emerging data with a focus on antifolates.
@en
Antimetabolites and cancer: emerging data with a focus on antifolates.
@nl
type
label
Antimetabolites and cancer: emerging data with a focus on antifolates.
@ast
Antimetabolites and cancer: emerging data with a focus on antifolates.
@en
Antimetabolites and cancer: emerging data with a focus on antifolates.
@nl
prefLabel
Antimetabolites and cancer: emerging data with a focus on antifolates.
@ast
Antimetabolites and cancer: emerging data with a focus on antifolates.
@en
Antimetabolites and cancer: emerging data with a focus on antifolates.
@nl
P2860
P1476
Antimetabolites and cancer: emerging data with a focus on antifolates.
@en
P2093
Giorgio V Scagliotti
Giovanni Selvaggi
P2860
P304
P356
10.1517/13543776.16.2.189
P407
P577
2006-02-01T00:00:00Z